JoanneE.FilickoMD
Hematology • Philadelphia, PAHematologic Oncology
Fellowship Program Director, Hematology and Medical Oncology Thomas Jefferson University Hospital Director of Inpatient Operations, Medical Oncology Thomas Jefferson University Hospital
Dr. Filicko is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
925 Chestnut Street
Suite 320
Philadelphia, PA 19107Phone+1 215-955-8874Fax+1 215-955-2340
Summary
- Dr. Joanne Filicko is a hematologist in Philadelphia, PA and is affiliated with Thomas Jefferson University Hospitals. She received her medical degree from Drexel University College of Medicine and has been in practice 25 years. She specializes in hematologic oncology and is experienced in amyloidosis, hematologic oncology, myelodysplasia, myelofibrosis, and hematopoietic stem cell transplantation.
Education & Training
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHFellowship, Hematology and Medical Oncology, 1995 - 1998- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Internal Medicine, 1992 - 1995
Drexel University College of MedicineClass of 1992
Certifications & Licensure
DE State Medical License 2023 - 2025
NJ State Medical License 2019 - 2025
PA State Medical License 1993 - 2024- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Patient-Centered Specialty Practice Recognition Program National Committee for Quality Assurance, 2014-2017
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2011-2013
Publications & Presentations
PubMed
- 1 citationsPhase I/II study of bendamustine in combination with ofatumumab, carboplatin, etoposide (BOCE) for relapsed or refractory aggressive B-cell non-Hodgkin lymphoma.Jonathan Pan, Sushil Ghimire, S. Onder Alpdogan, Andrew E. Chapman, Matthew Carabasi
Leukemia & Lymphoma. 2021-02-23 - 8 citationsFinal outcomes of escalated melphalan 280 mg/m2 with amifostine cytoprotection followed autologous hematopoietic stem cell transplantation for multiple myeloma: high C...Parameswaran Hari, Donna E. Reece, Jasleen K Randhawa, Neal Flomenberg, Dianna S. Howard
Bone Marrow Transplantation. 2019-02-01 - 2 citationsRelapsed Multiple Myeloma Presenting as Intracranial Plasmacytoma and Malignant Pericardial Effusion following Recent Allogeneic Stem Cell Transplantation.Jonathan Pan, Jason Chen, Joanne Filicko, Dolores Grosso, Michelle Nagurney
Case Reports in Oncology. 2017-05-01
Grant Support
- Immune Recovery Following LLME Treated Cell TherapyNational Institute Of Allergy And Infectious Diseases2002–2006
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
